Vertex Pharmaceuticals, a leading drugmaker based in Boston, has announced impressive financial performance in the third quarter. The company's profit has risen to $1.04 billion, or $3.97 per share, compared to $930.5 million, or $3.59 per share, in the same period last year. This exceeds analysts' expectations of $3.50 per share. When adjusting for one-time items, the adjusted … [Read more...] about Vertex Pharmaceuticals Reports Strong Q3 Results
Footer
